GlassScriptPhysician profile
Stephen D Cahill
NPI 1295725620
$9,822.90
in general payments reported to CMS, 2019-2025
25 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $4,206 · 2021: $4,269 · 2022: $191 · 2023: $321 · 2024: $367 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822 · Education: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.50 |
| Education | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,663.03 | 2020-2025 | Da Vinci Surgical System |
| Allergan, INC. | $164.58 | 2019-2022 | |
| Stryker Corporation | $148.85 | 2019 | |
| Integra Lifesciences Corporation | $114.09 | 2022-2025 | Integra, Surgimend, Omnigraft |
| Davol INC. | $111.93 | 2023 | Phasix Mesh, Powerport Clearvue Isp Implantable Port |
| Abbvie INC. | $95.09 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Tela Bio, INC. | $77.86 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kyowa Kirin, INC. | $68.87 | 2022-2025 | Poteligeo |
| Csl Behring | $57.65 | 2023-2024 | Kcentra |
| Innocoll Pharmaceuticals Limited | $34.75 | 2022 | |
| Bard Peripheral Vascular, INC. | $32.54 | 2021-2022 | |
| Ucb, INC. | $32.20 | 2025 | Bimzelx |
| Heron Therapeutics, INC. | $27.08 | 2022 | |
| Tactile Systems Technology INC | $21.69 | 2025 | Nimbl, Flexitouch Plus |
| Hologic INC | $20.30 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17.95 | 2023 | Ligasure |
| Astrazeneca Pharmaceuticals LP | $17.76 | 2024 | Andexxa |
| Acell, INC. | $16.27 | 2019 | |
| Galderma Laboratories, L.P. | $16.08 | 2019 | |
| Aroa Biosurgery Incorporated | $15.99 | 2023 | |
| Acera Surgical, INC. | $15.74 | 2025 | Restrata Wound Matrix |
| Mayne Pharma Commercial LLC | $15.17 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $14.14 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.07 | 2020 | |
| Shire North American Group INC | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Cahill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.